MAPT and early-onset autosomal dominant Alzheimer disease: On the other hand, physiological inhibitors for Tau fibrillization, such as molecular chaperone heat shock protein 70 (Hsp70) [6], [7], hold promise for development of novel strategies for treatment and early diagnosis of Alzheimer disease.